School of Medicine and Health Sciences, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Departments of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
J Eur Acad Dermatol Venereol. 2023 Apr;37(4):763-771. doi: 10.1111/jdv.18819. Epub 2023 Jan 4.
Fatigue is a symptom that can negatively impact patients' quality of life. However, the relationship of AD with fatigue has not been fully studied, especially in children.
To determine the prevalence of fatigue in AD patients, and whether AD severity, demographics and comorbidities are associated with increased fatigue in children.
A cross-sectional observational study was performed among 248 children with AD. Paediatric patients (ages 8-17 years) and parents (of children ages 0-17 years) completed a questionnaire, including demographics, history of atopic comorbidities and validated severity measures of AD, itch, pain, sleep disturbance, sleep-related impairment and fatigue. AD severity was also assessed by clinician-reported Eczema Area and Severity Index (EASI), Scoring AD (SCORAD) and Investigator's Global Assessment (IGA). Fatigue was assessed using Patient Reported Outcome Measurement Information System (PROMIS) Pediatric Fatigue T-score.
Most children with AD had no (38.6%) or mild (32.1%) fatigue, with fewer having moderate (27.2%) or severe (2%) fatigue. Moderate/severe PROMIS Pediatric fatigue T-scores were increased with moderate (25.7%/1.4%) and severe (39.3%/5.4%) IGA vs. mild IGA (18.0%/0.0%) and those with 5-6 (44.4%/0.0%) and 7 (44.2%/5.2%) nights of SD from eczema. Moderate-severe PROMIS Pediatric Fatigue T-scores were associated with history of hay fever (adjusted OR [95% Cl]: 2.803 [1.395-5.632]) and family income (<$100,000: 3.049 [1.294-7.181]), but inversely with Black (0.40 [0.168-0.969]) and AAPI (0.285 [0.094-0.859]) race. In multivariable regression models controlling for demographic factors, PROMIS Pediatric Fatigue T-score was significant with more severe scores for IGA, POEM, EASI, SCORAD, NRS-itch, SCORAD-itch, average itch in the past 7 days, PROMIS Pediatric Pain severity, PROMIS Pediatric SD, PROMIS Pediatric SRI, SCORAD-sleep and more frequent SD from AD.
Fatigue is a common yet underappreciated symptom in children with AD, particularly those with moderate-severe AD, and warrants more attention in clinical practice and trials.
疲劳是一种会对患者生活质量产生负面影响的症状。然而,AD 与疲劳之间的关系尚未得到充分研究,尤其是在儿童中。
确定 AD 患者疲劳的发生率,以及 AD 的严重程度、人口统计学特征和合并症是否与儿童疲劳的增加有关。
对 248 例 AD 患儿进行横断面观察性研究。儿科患者(8-17 岁)及其家长(0-17 岁儿童)完成一份调查问卷,内容包括人口统计学特征、特应性合并症病史以及 AD 的严重程度、瘙痒、疼痛、睡眠障碍、睡眠相关损害和疲劳的验证性严重程度测量。AD 的严重程度也由临床医生报告的 Eczema Area and Severity Index(EASI)、Scoring AD(SCORAD)和 Investigator's Global Assessment(IGA)进行评估。疲劳使用患者报告的结局测量信息系统(PROMIS)儿童疲劳 T 评分进行评估。
大多数 AD 患儿无(38.6%)或轻度(32.1%)疲劳,仅有较少的患儿为中度(27.2%)或重度(2%)疲劳。中度/重度 PROMIS 儿童疲劳 T 评分随中度(25.7%/1.4%)和重度(39.3%/5.4%)IGA 而增加,与轻度 IGA(18.0%/0.0%)相比,且与 5-6(44.4%/0.0%)和 7(44.2%/5.2%)晚出现瘙痒的 SD 相关。中度/重度 PROMIS 儿童疲劳 T 评分与特应性鼻炎病史(调整后的 OR [95%CI]:2.803 [1.395-5.632])和家庭收入(<$100,000:3.049 [1.294-7.181])相关,但与黑人(0.40 [0.168-0.969])和亚太裔美国人(0.285 [0.094-0.859])种族呈负相关。在控制人口统计学因素的多变量回归模型中,PROMIS 儿童疲劳 T 评分与 IGA、POEM、EASI、SCORAD、NRS-瘙痒、SCORAD-瘙痒、过去 7 天平均瘙痒、PROMIS 儿童疼痛严重程度、PROMIS 儿童 SD、PROMIS 儿童 SRI、SCORAD-睡眠和 AD 更频繁的 SD 显著相关。
疲劳是 AD 儿童常见但被低估的症状,尤其是中重度 AD 患儿,在临床实践和临床试验中应更加重视。